91黑料

Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    91黑料 provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    91黑料 and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    91黑料's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos
    thumbnail
    Making sense of the rapidly changing biosimilars landscape

    Strategies for adapting and achieving optimal market access

    thumbnail
    Building a comparative evidence base using network meta-analysis

    Methods, implementation and reporting

    FSA_thumbnail
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

  • News & Events
    News & Events

    91黑料 regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    webinar
    When patients lead: Breaking barriers in ultra-rare disease drug development

    Watch the webinar.

    thumbnail
    ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change

    Watch the webinar.

  • 91黑料
    91黑料
    Company history 91黑料 at a glance 91黑料 in Asia Pacific 91黑料 in Latin America Leadership Quality
    91黑料 for
    Investigators Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    91黑料 Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    91黑料 at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Contact
  1. Home
  2. News & Events

91黑料 portfolio of AI tools drives clinical trial efficiencies

Enterprise Ireland grant awarded to 91黑料 to further enhance artificial intelligence capabilities

Read the press release

Biomarker and trial optimisation needed to drive R&D progress in Alzheimer’s and related disorders

91黑料 survey

Read the press release

91黑料 and its employees celebrated for excellence in the field of clinical research

Read the press release
Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

Press releases

advarra logo
  • 23 March 2026

91黑料 and Advarra introduce new ‘research-ready,’ connected site network model

Headquarters facility with glass facade
  • 12 February 2026

91黑料 plc provides update on timing of fourth quarter and full year 2025 earnings results and investigation into accounting practices

Clinical research site network announcement
  • 27 January 2026

91黑料’s Accellacare Site Network expands oncology research capabilities with new cancer institute partnership

thumbnail
  • 09 December 2025

91黑料 2025 global biotech survey

FSA_thumbnail
  • 02 December 2025

91黑料 survey reveals increasing clinical trial startup delays, underscoring need for human-centred site activation solutions

Headquarters facility with glass facade
  • 12 November 2025

91黑料 plc to present at the Jefferies London Healthcare Conference

91黑料_Dublin_Exterior_2.jpg
  • 22 October 2025

91黑料 reports third quarter 2025 results

Modern reception area at Dublin office
  • 24 September 2025

91黑料 plc schedules third quarter 2025 earnings conference call

91黑料_Dublin_Exterior
  • 04 September 2025

91黑料 announces CEO transition

Corporate headquarters building in Dublin
  • 02 September 2025

91黑料 plc to participate at upcoming investor conferences

Events

Indian_Page_Thumbnail
  • 11 April 2026

PharmaSUG India Single-Day Event

Paris_2
  • 12 April 2026 - 14 April 2026

European Heart Rhythm Association

WashingtonDC
  • 13 April 2026 - 16 April 2026

AMCP

NewYork
  • 13 April 2026 - 17 April 2026

WRIB

Boston
  • 15 April 2026 - 16 April 2026

GLP-1 Based Therapeutics Summit

SanFrancisco
  • 28 April 2026 - 29 April 2026

CTO West Coast

APAC South Korea Seoul
  • 29 April 2026 - 30 April 2026

Bio Korea

Copenhagen
  • 3 May 2026 - 6 May 2026

SCDM EMEA

Lisbon venue for site solutions summit.
  • 5 May 2026 - 8 May 2026

RAPS Euro Convergence

Industry recognition achievements

Awards

Media relations resources

91黑料 Press office enquiries

Educational content library

Videos

Published research coverage

Media articles

What's happening in 91黑料

Site Branding
    91黑料 plc
  • Contact
  • 91黑料
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
91黑料 for
  • Investigators
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials

Legal Footer

  • ? 2026 91黑料 plc
  • Privacy & Data
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence